Skip to main content
Header image

Sarková Alexandra

Derivatives of mesagenin with potential anticancer activity

Supervisor: Urban Milan Ph.D.

Status: Ongoing from 2025.

Schreiber Šimon

Comparison of methods for measuring the viability of cell lines with different levels of CHIP protein expression after exposure to proteotoxic stress

Supervisor: Kiška Adam

Status: Ongoing from 2026.

Skramusky Simon

Biomarkers in meningiomas

Supervisor: Koudeláková Vladimíra Ph.D.

Status: Ongoing from 2025.

Skramuský Šimon

Biomarkers in Central Nervous System Tumors

Status: Ongoing from 2024.

Smrčková Nela

Role of CuEt, GSK3, and Syk inhibitors on survivin protein in colon carcinoma cell lines

Supervisor: De Sanctis Juan Bautista Ph.D.

Status: Ongoing from 2026.

Trávníčková Lucie

Biomarkers in glial tumors

Supervisor: Koudeláková Vladimíra Ph.D.

Status: Ongoing from 2025.

Třeštík Jan

Targeting cell stress pathways in cancer

Supervisor: Škrott Zdeněk Ph.D.

Status: Ongoing from 2024.

Vévodová Karolína

Increasing the sensitivity of targeted proteomics

Supervisor: Oždian Tomáš Ph.D.

Status: Ongoing from 2022.

Zatloukalová Klára

3D Cancer–Immune Cell Spheroids for Studying Stress Protein-Driven Modulation of Cytotoxicity

Supervisor: Valentini Viktor M.Sc.

Status: Ongoing from 2025.

Zbořilová Pavlína

Single-cell proteomics: optimization of sample preparation for LC-MS/MS analysis

Supervisor: Václavková Jana Ph.D.

Status: Ongoing from 2026.